SUMMARY
Assessment of the safety of drug candidates in early research and development (R&D) stage holds the key to the successful drug development. Toxicogenomics is one of the promising approaches using omics techniques since a number of 'omics databases is rapidly growing. Although many of these databases are open to the public, there remain some barriers for biologists regardless of their bioinformatics skills. Toxygates was originally developed as a user-friendly interface for Open TG-GATEs, which is one of the largest and most widely used toxicogenomics databases. Since the original Toxygates was developed to enable users to display the gene expression values obtained by selected compounds or experimental conditions for genes of interest, there were some limitations as an analytical platform. To overcome this situation, significant improvements have been added and finally, a new version of Toxygates allows users to analyze the data such as creating heatmap for visualization of gene expression profile, performing hierarchical clustering and creating a dendrogram with interactive display, performing several types of enrichment analysis such as gene ontology and pathways and uploading user data for further analysis. As a case study, we used Toxygates to successfully find novel insights that the hepatotoxicity caused by well-studied PPARα agonist WY-14643 may include the disruption of intracellular calcium dynamics and imbalance between PPARα signaling and Wnt signaling.
INTRODUCTION
The growth of "omics" techniques by utilizing genome information has been diversifying research approaches in biology. Drug discovery research is not an exception, and 'omics techniques are widely used to assess the efficacy and safety of drug candidates. Assessment of the safety of drug candidates in early R&D stage holds the key to the successful drug development since it is reported that cardiac toxicity (33%) and liver toxicity (29%) were top-ranked as primary reasons for drug withdrawals from the US, EU and Asian markets from 1998-2008 [1] . The research approach to assess the safety of compounds including drug candidates by utilizing their effect on gene expression profiles at organs (or in vitro model of such organs) is called "toxicogenomics", and several toxicogenomics databases have been developed to meet the increasing demand for data sharing in this area [2, 3] .
Open TG-GATEs is one of the largest and most widely used toxicogenomics databases [4] , which stores about 24,000 microarray profiles of 170 different compounds obtained from rat (in vitro and in vivo) and human (in vitro), with their pathology data, obtained by the Japanese Toxicogenomics Project consortium (TGP) [5] . Although this database is open to the public and widely used all over the world, still there remain some barriers for biologists to explore this gold mine, such as i) download of huge amount of datasets is required, ii) programming for data analysis is required, and iii) access to third party database for annotation (e.g. gene ontology (GO), signaling pathway) is required. It is expected that the toxicogenomics would be an even more powerful approach to assess or predict the safety/toxicity of compounds if these barriers for biologists to access Open TG-GATEs data would be lowered.
Toxygates was originally developed for this purpose, which enables to display the gene expression intensity values obtained by selected compounds and experimental conditions for genes of interest [6] . 
RESULTS
In this section, we report new analytical functions in this version of Toxygates.
Visualization of gene expression profiles by heatmap
A heatmap is a popular way to visualize gene expression profiles.
In this version of Toxygates, users can create heatmap by simple operation. Users can select expression values to be used for heatmap (Log2(fold change), Normalized intensity) and dendrograms associated with the heatmap.
Hierarchical clustering with interactive display
The result of hierarchical clustering can be added as a dendrogram to a heatmap. Users can select clustering algorithms (ward.D, ward.D2, single, complete, average, mcquitty, median, centroid) and the definition of distance (Euclidean, maximum, Manhattan, Canberra, binary, Pearson, abspearson, Spearman, Kendall) for genes and compounds.
To perform Ward's hierarchical clustering, users are encouraged to use "ward.D2" instead of "ward.D" [7] . Users can group genes (shown in rows) or selected compounds and experimental conditions (shown in columns) into several subgroups according to their similarity by setting a cut-off threshold for gene clustering. The gene lists obtained by this operation can be saved and used for further analysis directly.
Enrichment analysis by integration with TargetMine
Functional integration with TargetMine enables to perform several types of enrichment analysis online. TargetMine is an integrated data warehouse for drug discovery [8, 9] , and this platform outputs all the results of covering enrichment analysis (e.g. KEGG pathways [10] , GO terms [11] , GOSlim terms [12] and Integrated Pathway Clusters (IPCs) [13] ) in one window when gene list is used as an input. The function to display the summary of enriched features obtained from TargetMine is implemented in this version of Toxygates. In addition, gene lists can be directly transferred between Toxygates and TargetMine, which enables users to perform in-depth data analysis.
User data upload
Users may wish to compare gene expression profile of their data to those stored in Open TG-GATEs. To support this kind of analysis and broaden the usability of the database, a user data upload function has been added to Toxygates. In this version of Toxygates, Affymetrix data from GeneChip R Mouse Genome 430 2.0 Array, Rat Genome 230 2.0 Array and Human Genome U133 Plus 2.0 is supported. The uploaded data is protected by a user key, and it is kept private by default.
Case study: molecular mechanism of WY-14643 hepatotoxicity
The WY-14643 (pirinixic acid) is a failed drug as an anti-hypercholesterolemic agent [14] , which is known to cause hepatotoxicity such as carcinogenicity at liver in rodents. It is well known that this compound is a selective agonist of Peroxisome Proliferator-Activated Receptor alpha (PPARα). PPARα plays a key role in fatty acid metabolism, and its agonists such as fibrates were regarded as promising drug candidates against dyslipidemia.
However, safer drugs with adequate efficacy are desired because of the side effects of existing drugs that work as PPARα agonists, including hepatotoxicity [15] . We explored the molecular mechanism of hepatotoxicity caused by WY-14643 with new functions in Toxygates.
The pathology and enriched GO showed that the tendency changed between 4day treatment and 8day treatment (M dose: 30mg/kg BW). To investigate the event that happened between these experimental conditions, we performed Student's t-test between M dose/4day treatment and M dose/8day treatment and extracted probes with significantly different expression intensities (cutoff p-value: 0.01). These probes were divided into 3 clusters by using heatmap function, and pathway enrichment analysis showed that genes related to "Beta-catenin independent WNT signaling", "Ca2+ pathway", or "Protein processing in endoplasmic reticulum (ER)" at integrated pathway cluster level were enriched in each cluster (Figure 1) .
By comparing the expression patterns of treatment of WY-14643 or calcium channel blocker, amlodipine, whose microarray profiles were obtained from DrugMatrix (dose: 0.3 mg/kg BW (L dose) or 19 mg/kg BW (M dose)) and uploaded by "user data upload function" on Toxygates, we obtained novel insights such as i) genes related to "beta-catenin independent Wnt signaling" were upregulated by long-term treatment (gray cluster), ii) genes related to "Ca2+ pathway" were upregulated by 4day treatment of WY-14643 (turquoise cluster) and amlodipine, and iii) genes related to "protein processing in ER", including unfolded protein response markers such as hspa5/grp78, were downregulated by long-term treatment of WY-14643 (blue cluster). These results suggest that imbalance between PPARα signaling and Wnt signaling can be one of the underlying mechanisms of hepatotoxicity by WY-14643.
DISCUSSION
Even though Open TG-GATEs data has been widely utilized in bioinformatics / toxicogenomics area, there are still limited number of web applications that utilize this database: LTMap [16] and ToxDBScan [17] . These applications aim to obtain a list of ranked drugs according to the similarity between the input gene expression pattern and that caused by drugs in a reference database such as Open TG-GATEs. By contrast, Toxygates now enables users to perform more flexible data analysis including gene selection according to their expression patterns shown in interactive heatmap with hierarchical clustering and comprehensive enrichment analysis by integration with TargetMine. The case study suggested that this sophisticated platform successfully extracted novel insights related with the molecular mechanism of hepatotoxicity caused by WY-14643, in spite of the fact that WY-14643 is one of the most well studied PPARα agonists. We believe that this new version of Toxygates will let users reap the rewards of large omics data and foster drug discovery research.
